Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2026-01-17 @ 3:04 AM
Study NCT ID:
NCT02309892
Status:
TERMINATED
Last Update Posted:
2024-06-03
First Post:
2013-04-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC
Sponsor:
Helix BioPharma Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LDOS001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |